Global Anesthesia Gas Scavenging System Market Is Estimated To Witness High Growth Owing To Increasing Focus on Patient Safety

The global Anesthesia Gas Scavenging System Market is estimated to be valued at US$ 5.5 billion in 2022 and is expected to exhibit a CAGR of 5.5% over the forecast period, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: Anesthesia gas scavenging systems are used to remove waste anesthetic gases, ensuring the safety of healthcare providers and patients during anesthesia procedures. These systems prevent the accumulation of anesthetic gases in the operating room, maintaining a safe working environment. The advantages of anesthesia gas scavenging systems include reduced exposure to anesthetic gases, decreased risk of adverse health effects, and compliance with safety regulations. B) Market Key Trends: One key trend in the anesthesia gas scavenging system market is the increasing focus on patient safety. Healthcare providers are becoming more aware of the potential risks associated with exposure to waste anesthetic gases. This has led to the implementation of strict safety guidelines and regulations, driving the demand for anesthesia gas scavenging systems. For example, the Occupational Safety and Health Administration (OSHA) in the United States recommends the use of scavenging systems to minimize exposure to waste anesthetic gases. C) PEST Analysis: - Political: Governments across the globe are implementing regulations and guidelines to ensure the safety of healthcare providers and patients. These regulations drive the adoption of anesthesia gas scavenging systems. - Economic: The growing healthcare industry and increasing number of surgical procedures contribute to the growth of the anesthesia gas scavenging system market. - Social: Awareness about the potential health risks associated with waste anesthetic gases is increasing among healthcare providers, leading to higher demand for scavenging systems. - Technological: Advancements in technology have led to the development of more efficient and user-friendly anesthesia gas scavenging systems. D) Key Takeaways: - The Global Anesthesia Gas Scavenging System Market Size is expected to witness high growth, exhibiting a CAGR of 5.5% over the forecast period, due to increasing focus on patient safety. Healthcare providers are increasingly adopting anesthesia gas scavenging systems to comply with safety regulations and minimize the risks associated with waste anesthetic gases. - North America is expected to be the fastest growing and dominating region in the anesthesia gas scavenging system market. The region has well-established healthcare infrastructure and stringent safety regulations, driving the demand for scavenging systems. - Key players operating in the global anesthesia gas scavenging system market include Beacon Medaes, CGA 30 MEDEVICE system by DeviceInformed, MEC medical Ltd., MidMark, Pneumatech Medical Gas Solutions (PMGS), Coltronics system Ltd., Becker pumps, and G.Samaras S.A. In conclusion, the global anesthesia gas scavenging system market is expected to witness substantial growth in the coming years. The increasing focus on patient safety and the implementation of strict safety regulations drive the demand for anesthesia gas scavenging systems. North America is expected to be the fastest growing region, driven by its well-established healthcare infrastructure and stringent safety regulations. Key players in the market are continuously developing new and innovative products to cater to the growing demand for anesthesia gas scavenging systems.

The new research on Anesthesia Gas Scavenging System gives a fundamental data and factually assessed information about the industry worldwide.

#Anesthesia Gas Scavenging System Market - Click to Know the Future

The anesthetic gas scavenging system removes anesthetic gas mixtures in areas fitted with nitrous oxide terminal units, such as operating rooms. The scavenging system collects the waste gases from the exhaust port of the anesthetic circuit or ventilator, transfers them to a receiving system and releases the gases in the external environment. Anesthetic gases such as nitrous oxide and some volatile agents may have hazardous impact on health of surrounding people, and thus, it is important to use the anesthetic scavenging system.

Supportive government regulations regarding work safety fueling market growth

The government regulations for work area safety is a key driver for promoting the use of anesthesia gas scavenging system. For instance, The Occupational Safety and Health Act requires employers to comply with hazard-specific safety and health standards.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/418

The use of this system is advantageous as there is no set up cost for it and it can move with the machine. The system can be activated by remote switches which can be placed at any location it may be inside the anesthetic room or near by the room. It ensures the safe working environment for the working staff with the most stringent occupational exposure standards. The barriers to use of this system are continuing cost of replacement and the cumbersome process involved in the same.

Major players in the anesthesia scavenging system market

Wuxi Huana Healthcare Techniques Co. Ltd, Blue-Zone Technologies Ltd. has created some of the world’s most innovative medical technology (medtech) innovations, Centralsorb and Deltasorb systems that remove and store GHG emissions from medical buildings to remove anesthetic gases, Beacon Medaes, CGA 30 MEDEVICE system by DeviceInformed, MEC medical Ltd., MidMark, Pneumatech Medical Gas Solutions (PMGS), Coltronics system Ltd., Becker pumps, G.Samaras S.A. Click To Read More On Anesthesia Gas Scavenging System Market

I'm making a post just for anesthetics/medications related to/used often in anesthesia since my anesthesia rotation is next:

Succinylcholine is a nicotinic ACh receptor agonist at the motor end plate. It causes depolarization until the end plate becomes desensitized and paralysis occurs. SUX is metabolized by pseudocholinesterase. Deficiency in pseudocholinesterase occurs in those with a genetic polymorphism (BCHE gene), so it takes longer for these pts to be able to breathe on their own again after receiving SUX. These pts also have prolonged effects from mivacurium and cocaine. Mivacurium is an ACh receptor antagonist--it binds to the ACh receptor, but doesn't activate it. So it competes with ACh.

So succinylcholine is a depolarizing neuromuscular blocker whereas rocuronium, vecuronium, pancuronium, mivacurium, atracurium, and tubocurarine are non-depolarizing neuromuscular blockers. I'm looking at the First Aid for Step I page that talks about these drugs and it says that you can't reverse phase I of SUX and it's potentiated by AChE inhibitors. But phase II is reversible with AChE inhibitors. Gotta review all of this.

----------

From Wikipedia:

Butyrylcholinesterase (HGNC symbol BCHE; EC 3.1.1.8), also known as BChE, BuChE, pseudocholinesterase, or plasma (cholin)esterase, is a nonspecific cholinesterase enzyme that hydrolyses many different choline-based esters. In humans, it is made in the liver, found mainly in blood plasma, and encoded by the BCHE gene.

It is very similar to the neuronal acetylcholinesterase, which is also known as RBC or erythrocyte cholinesterase. The term "serum cholinesterase" is generally used in reference to a clinical test that reflects levels of both of these enzymes in the blood. Assay of butyrylcholinesterase activity in plasma can be used as a liver function test as both hypercholinesterasemia and hypocholinesterasemia indicate pathological processes. The half-life of BCHE is approximately 10 to 14 days.

Butyrylcholinesterase may be a physiological ghrelin regulator.

Pseudocholinesterase deficiency results in delayed metabolism of only a few compounds of clinical significance, including the following: succinylcholine, mivacurium, procaine, heroin, and cocaine. Of these, its most clinically important substrate is the depolarizing neuromuscular blocking agent, succinylcholine, which the pseudocholinesterase enzyme hydrolyzes to succinylmonocholine and then to succinic acid. In individuals with normal plasma levels of normally functioning pseudocholinesterase enzyme, hydrolysis and inactivation of approximately 90-95% of an intravenous dose of succinylcholine occurs before it reaches the neuromuscular junction. The remaining 5-10% of the succinylcholine dose acts as an acetylcholine receptor agonist at the neuromuscular junction, causing prolonged depolarization of the postsynaptic junction of the motor-end plate. This depolarization initially triggers fasciculation of skeletal muscle. As a result of prolonged depolarization, endogenous acetylcholine released from the presynaptic membrane of the motor neuron does not produce any additional change in membrane potential after binding to its receptor on the myocyte. Flaccid paralysis of skeletal muscles develops within 1 minute. In normal subjects, skeletal muscle function returns to normal approximately 5 minutes after a single bolus injection of succinylcholine as it passively diffuses away from the neuromuscular junction. Pseudocholinesterase deficiency can result in higher levels of intact succinylcholine molecules reaching receptors in the neuromuscular junction, causing the duration of paralytic effect to continue for as long as 8 hours. This condition is recognized clinically when paralysis of the respiratory and other skeletal muscles fails to spontaneously resolve after succinylcholine is administered as an adjunctive paralytic agent during anesthesia procedures. In such cases respiratory assistance is required.

So basically, if you don't have sufficient pseudocholinesterase (aka butyrylcholinesterase) to degrade SUX, there will be more SUX than normal at the neuromuscular junction. Therefore it will take longer for the effects of SUX to wear off.

Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage.

Finally, pseudocholinesterase metabolism of procaine results in formation of paraaminobenzoic acid (PABA). If the patient receiving procaine is on sulfonamide antibiotics such as bactrim, the antibiotic effect will be antagonized by providing a new source of PABA to the microbe for subsequent synthesis of folic acid.

^ interesting. So giving procaine negates the effects of TMP-SMX. SMX is a PABA analogue that prevents bacteria from making folic acid by competing with real PABA. Giving procaine is like givine PABA, so the effects of SMX are basically cancelled out by procaine (Novocain). TMP inhibits dihydrofolate reductase, so the bacteria can't make tetrahydrofolate.

Prophylactic countermeasure against nerve gas

Butyrylcholinesterase is a prophylactic countermeasure against organophosphate nerve agents. It binds nerve agent in the bloodstream before it can exert effects in the nervous system. Because it is a biological scavenger (and universal target), it is currently the only therapeutic agent effective in providing complete stoichiometric protection against the entire spectrum of organophosphate nerve agents.

Prophylactic against cocaine addiction

An experimental new drug was developed for the potential treatment of cocaine abuse and overdose based on the pseudocholinesterase structure (it was a human BChE mutant with improved catalytic efficiency). It was shown to remove cocaine from the body 2000 times as fast as the natural form of BChE. Studies in rats have shown that the drug prevented convulsions and death when administered cocaine overdoses.

Transplantation of skin cells modified to express the enhanced form of butyrylcholinesterase into mice enables the long-term release of the enzyme and efficiently protects the mice from cocaine-seeking behavior and cocaine overdose.

---------

Midazolam (trade name Versed) not only sedates the pt, but also causes amnesia, which is a desired effect so the pt won't remember the procedure, which is why it's often used in colonoscopies (one of the pulm fellows told me that).

Avoid propofol in hemodynamically unstable (i.e., low BP) pts.

Etomidate does not cause cardiovascular depression, unlike propol. Propofol, etomidate, and ketamine have rapid onset of action and short duration, so they’re often used for induction. Propofol is a GABA agonist; can cause vasodilation-> hypotension. Etomidate is also a GABA agonist, but doesn’t cause vasodilation. Etomidate prevents cortisol synthesis, which can cause adrenocortical suppression; so it is not used in pts with septic shock. Ketamine is an N-Methyl-D-Aspartate (NMDA) antagonist; it is like PCP; causes release of catecholamines-> bronchodilation, increased HR, positive inotropy. So in pts who are hemodynamically unstable, you would use an anesthetic like etomidate or ketamine, which either have no effect on hemodynamics (etomidate) or improve hemodynamics (ketamine); and you would avoid propofol, which would worsen hemodynamic instability.

Train-of-four stimulation is when you electrically stimulate a peripheral nerve 4 times and record the response of the muscles. SUX is a depolarizing neuromuscukalar blocker used for rapid sequence intubation. During phase I blockade, the muscles respond to a lesser extent with the same response each time the nerves are stimulated. If SUX is used long enough or the pt has pseudocholinesterase deficiency-> nondepolarizing block, which causes reduced muscle twitch each time you stimulate the nerve. I don't recall ever learning about train-of-four (TOF) stimulation.

Nondepolarizing neuromuscular junction blockade with vecuronium causes decreased muscle twitch with each stimulation. Vecuronium blocks ACh receptors. Vecuronium also blocks presynaptic ACh receptors.

Anesthesia Device Market Size, Share, Outlook, and Analysis, 2018-2026

Anesthesia is a medical procedure to control pain during the course of a surgery. Anesthesia monitors have been widely used in a number of healthcare organizations, clinics and outpatient surgery centers to track the patient's vital signs such as blood pressure and temperature, while they are under sedation in the operating theater.

Increasing approvals from healthcare regulatory authorities for new technologies is expected to drive the market growth. For instance, in March 2019, Masimo Corp. received CE marking for its Next Generation SedLine brain function monitoring for pediatric patients. Sedline helps surgeons to monitor the state of the brain of pediatric patients under anesthesia with bilateral data acquisition and processing of four leads of electroencephalogram (EEG) signals.

Get a PDF Sample of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2556

Moreover, in June 2016, GE Healthcare launched Carestation 600 Series — an affordable suite of anesthesia solutions — at the Vietnam Congress of Anaesthesiology 2016. The new suit consists of two machines, monitoring devices and advanced ventilation tools, for balancing user interface design with intelligent tools to help physicians prevent misuse and medical errors in the operating room.

Market Dynamics

Anesthesia devices are used commonly in all types of surgeries as they are designed to offer an accurate and continuous supply of mixed medical gases with anesthetic vapors, which are delivered to patient at a safe pressure and flow. According to the Centers for Disease Control and Prevention (CDC), in 2010, 16 million operative procedures were performed in the U.S. Increasing number of patients suffering from respiratory diseases is expected to boost growth of the market. According to CDC, in 2016, around 24 million people, including over 6 million children suffered from asthma in the U.S.

Furthermore, increasing launch of advanced anesthesia workstations is expected to boost the market growth. For instance, in February 2012, Intersurgical launched two Anaesthetic Gas Scavenging System (AGSS) Pressure Relief Valves, one for use with 30mm scavenging tube and the other one for use with 22mm scavenging tube allowing the pressure to build up in the breathing system and preventing the patient from exhaling. These valves can be used to release pressure into the atmosphere, thereby reducing the pressure in the breathing system.

Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/2556

Market Outlook

For instance, in May 2018, the American Society of Anesthesiologists (ASA) and CAE Healthcare launched interactive, screen-based simulation training product line Anesthesia SimSTAT. Anesthesia SimSTAT – Appendectomy training is designed to offer physician anesthesiologists to manage challenging anesthetic emergencies in patients undergoing laparoscopic surgeries for acute appendicitis.

Presence of major player such as Medtronic plc, Getinge AB, and Draegerwerk AG & Co. KGaA in European countries is expected to drive growth of the Europe anesthesia device market. For instance, in November 2012, Covidien -- minimally invasive therapies division of Medtronic plc. — announced that UK-based National Institute for Health and Clinical Excellence (NICE) has approved the use of its electroencephalography (EEG)-based monitor — Bispectral Index (BIS) monitor— as an option for measuring depth of anesthesia.

Key players operating in the anesthesia device market include, GE Healthcare, Spacelabs Healthcare., Septodont Inc, Draegerwerk AG & Co. KGaA, Beijing Aeonmed Co., Ltd., HEYER Medical AG, ORICARE, Inc., Philips Healthcare, Becton Dickinson and Company, and Getinge AB.

Click To Continue Reading On Anesthesia Device Market

Anesthesia Delivery Systems Market SWOT Analysis and Regional Outlook from 2020-2026 |Drägerwerk |GE Healthcare |Maquet

Global “Anesthesia Delivery Systems” market is a detailed research study that helps provides answers and related questions with respect to the emerging trends and rise moment in this particular industry. It helps select each of the easily seen barriers to rise, apart from identifying the trends within various application sector of the global market.

The study focuses on the driving factors, restraints and hurdles for the expansion of the market. The research worker offers Industry insights with reference to the approaching areas within the business and therefore the impact of technological innovations on the expansion of the market.

Request for Free Sample Copy at: http://www.researchreportcenter.com/request-sample/1333757

Major Key Vendors:-

Drägerwerk, GE Healthcare, Maquet, Mindray Medical International, Penlon, Henin + Löwenstein, HERSILL, HEYER Medical, Medtronic, Oricare, Philips, Smiths Medical, Spacelabs Healthcare, Vincent Medical

Types is divided into:

Anesthesia Machine

Anesthesia Vaporizer

Ventilator

Breathing Circuit

Waste Gas Scavenging System

Applications is divided into:

Hospital

Clinic

Others

Significant Regions covered in this report:

North America, China, Rest of Asia-Pacific, UK, Europe, Central & South America, Middle East & Africa

Get Discount on this Report: http://www.researchreportcenter.com/check-discount/1333757

What the Anesthesia Delivery Systems report offers:

market definition of the worldwide Anesthesia Delivery Systems beside the analysis of various influencing factors like drivers, restraints, and opportunities.

Extensive analysis on the competitive landscape of worldwide Anesthesia Delivery Systems market.

Identification and analysis of small and macro factors are have an effect on on the expansion of the market.

Analysis of the various Anesthesia Delivery Systems market segments like sort, size, applications, and end-users.

It offers a descriptive analysis of demand-supply chaining within the international Pre Trade Risk Management answer Market.

Statistical Anesthesia Delivery Systems analysis of some important social science facts.

To Clear Any Query about Report, Please Refer Link: http://www.researchreportcenter.com/send-an-enquiry/1333757

Customization of the Report: This report can be customized as per your needs for additional data or countries.Please connect with our sales team ([email protected])

Cat Friendly Handling: Your Cat Deserves a Positive Experience at the Veterinary Clinic

Guest post by Ellen Carozza, LVT

Thanks to the internet, cats are the most popular pet, yet they receive less medical care than their canine counterparts. Join me and the Conscious Cat in this two part series on what actually happens when your cat is handled in the veterinary clinic, and how you and your cat can have that positive experience you’ve always wanted.

But first I need to take a step back and explain a few things…

Handling practices for cats

One of the top comments I see in many of my pet related posts on THE CAT LVT is how so many people don’t like how their cat is handled at the veterinary clinic.

In my 20+ years of being in veterinary medicine, I’ve seen quite the evolution of animal restraint in practice. So why are our handling practices for cats still so primitive? Is it because we don’t care to gain further knowledge and move forward in our standards of care? Is it fear of the animal itself? Or is it because “we’ve always done it this way?”

As pet guardians want to be more involved in their pets’ care, and as we treat the newer generation of pets, our industry needs to make much needed changes both in terms of treating patients and to keep a practice thriving. While these changes are happening, it feels like they are happening at a snail’s pace.

As veterinary professionals, we are dedicated to providing excellent care: care and compassion that is paid for by you, the client.

Veterinary medicine is categorized as a “for profit” industry, as pets by law are considered personal property for which you elect us to provide medical care. Yet I see on many Facebook forums for veterinary professionals how anti-cat they can be. How is this possible? We all work in this field for various reasons. To see the negative comments about our feline patients can be disheartening and downright embarrassing at times.

How can we as caregivers boast of our love for animals and then speak of them in a negative manner? I see cats labeled as “demons”, “aggressive”, “awful”, and many four-letter words that don’t need to be repeated. This is not only unprofessional and abhorrent behavior on the professionals’ part, it also means that they either do not understand the language of the cat, or they really don’t want to learn and work with them.

I’m not a fan of working with dogs. I never have been and I’m not afraid of admitting it. I don’t understand their language, and their presence can be too much for me to handle physically. I grew up with dogs. My family still has them as pets. I just prefer not to work with them. So what did I do? I found a practice that was exclusive to the species I wanted to work with: cats. There is nothing wrong with admitting that you don’t prefer to work with a particular species, but if you have made the choice to work at a mixed practice, you are expected to be kind, compassionate, and understanding regardless of what species your patient is.

Understanding cats sets up a more successful vet visit

Learning how a patient acts and reacts in a clinical setting can help set up a more successful visit. We as professionals need to make sure we are prepared in advance to make sure that happens. You as a client need to be honest about how your cat has behaved at previous veterinary visits so we can anticipate your and your cat’s needs accordingly.

The feline patient has a unique body language and can arrive at the clinic already stressed out. Those of us working the veterinary field need to learn how to understand the clear signals cats give us, and adjust our behavior accordingly to be able to work with them safely. In reality, these cats are scared, and are acting out in a manner completely appropriate to a situation they did not willingly put themselves in. Once that is understood, speaking their language gets easier, and they are quite rewarding to work with.

However, we do need your help. We need to know if your cat prefers certain staff members. We need to know if your cat needs or has been given an anxiolytic (medication to ease anxiety before the visit) in the past or might benefit from such medication, or if your cat needs to be sedated to handle.

Outdated restraint and anesthesia techniques

Unfortunately, the American Veterinary Medical Association (AVMA) still requires the veterinary professional to learn outdated restraint/anesthesia techniques for companion animals. Restraint methods such as scruffing, and even worse “tanking” or “boxing”, (putting the cat into an oxygen tank and running anesthetic gas into the tank to sedate them) are not only unsafe, but are considered outdated, cruel and unnecessary handling methods. They are also unsafe for the staff performing the task.

Not only does scruffing put dangerous stress on the cervical vertebrae, it can be painful for cats with arthritis and skin ailments. It also heightens the stress response.

Tanking and boxing is one of the worst anesthetic practices, as the patient cannot be accurately monitored. It causes severe cardiac depression. The cat’s fur becomes supersaturated with an anesthetic gas that the staff handling the cats are then going to inhale. A scavenging system is not designed to protect staff from gas inhalation when used with a tank, and is actually a violation of OSHA (Occupational Health and Safety Administration) standards. If a hospital does not care to update their anesthetic protocol to safer methods for pets and staff, it speaks volumes about the medical care provided and how staff are treated.

The AVMA needs to evolve in supporting safer, better methods of restraint and anesthesia techniques for cats, and removing the unsafe and outdated techniques taught in veterinary programs, so that our next generation of veterinary professionals are prepared to provide a more positive experience at the vet office!

There are better, safer methods of restraint for the feline patient.

The International Society of Feline Medicine (ISFM) currently has a “scruff free” campaign which advocates for respectful feline handling in a veterinary clinic. Check out their pledge and set of links here: https://icatcare.org/scruffing for further information. The AAFP also has a set of practice guidelines for handling the feline patient and can be found here: https://catvets.com/guidelines/practice-guidelines/handling-guidelines, and as a bonus they have a search engine to help you find the purrfect feline vet in your area: https://catfriendly.com/find-a-veterinarian/

Our goal in a Cat Friendly Practice®

Our goal in the cat friendly practice is to make sure your cat gets the medical care he or she needs and deserves, and that you understand what we are doing every step of the way. There is no need to be embarrassed at how your cat reacts at the vet office! It’s normal, expected behavior – we understand they are stressed out. We want to make sure that stress level is kept to a minimum for you and your cat(s) by being prepared in advance.

I wrote an article for Today’s Veterinary Nurse on understanding feline behavior in the clinical setting. It can provide detailed insight on how we categorize and work with, not against our feline patients. This can help you understand how we train to be better prepared for working with a variety of feline patients. You can find it here: https://todaysveterinarynurse.com/articles/behavior-understanding-the-cat/

It is encouraging that many clinics are becoming Cat Friendly or Fear Free. The staff at these clinics is specifically trained to have protocols in place to ease the stress of the animals that are presented for care. Look for the Cat Friendly Practice® logo by the American Association of Feline Practitioners (AAFP) on a clinic’s website or front door, or look for the Fear Free Certified® logo, as many mixed practices are training in that method because they treat more than just cats.

You want the people who you bring your pet in for medical attention excited about caring for them! If you don’t see that, it is your right as a client to seek care at a clinic where these methods are practiced. It is OK to get a second opinion.

Currently, there are over 26,000 animal hospitals in the United States. If you don’t like the practice you are with, find a practice that fits you and your cat’s needs.

When looking for a feline centric clinic, at a minimum check for the following:

● Cat Friendly Practice© or Fear Free Certified® logo ● Staff bios on a website that state they LOVE working with cats ● Does the practice have a quiet atmosphere, or separate canine and feline lobby areas and separate exam/hospital ward that cater to your cat’s emotional needs? ● Is the clinic willing to get your cat in for an appointment regardless of his or her stress level and previous negative experiences? ● A place that will honestly tell you who is working with your pet, what anesthetics are used, how, and who they are administered by ● Do they practice updated feline medicine and work with you and your cat’s lifestyle by using practice guidelines created by the AAFP? ● Do they perform all necessary tasks such as lab work in front of you or remove the cat from the room? ● Are they using cat friendly methods of handling and restraint? ● Are there credentialed veterinary technicians on staff?

Once you have your questions answered to your satisfaction, make an appointment.

A note from Ingrid: I think it’s a good idea to make an appointment without your cat when you are evaluating a veterinary clinic.  By going to see potential vets without your cat, you will be more relaxed.  Ask for a tour of the hospital.  If you want to speak with a veterinarian, offer to pay for an office visit.  Most vets won’t charge you for this introductory visit, but offering to pay for their time sets the right tone for a future relationship of mutual respect.  Come prepared with a list of questions. For more details on how to choose a cat friendly vet, watch this video.

Stay tuned for Part Two: How you can make your cat’s visit to the vet less stressful for your cat and what to expect during your visit.

Ellen Carozza, LVT is a technician at Nova Cat Clinic in Arlington, VA. You can learn more about Ellen on the NOVA Cat Clinic website, and you can find her on Instagram and Facebook.

The post Cat Friendly Handling: Your Cat Deserves a Positive Experience at the Veterinary Clinic appeared first on The Conscious Cat.

BLK Super Specialty Hospital is a 650-bedded hospital with dedicated 125 critical care beds with over 150 specialists across various super specialties making it one of the best hospitals in India. BLK Super Specialty Hospital has India’s largest Bone Marrow Transplant centre which is amongst the biggest in Asia as well. BLK Super Specialty Hospital includes more than 17 well equipped modular operation theatres with three stage air filtration and gas scavenging system to ensure patient safety. BLK Super Specialty Hospital has world class Operation Theatres which are fitted with best in class pendants, operating lights, anesthesia workstations and advanced information management system.

Drager Narkomed 2B Anesthesia Machine

Welcome to a Biomedical Battery specialist of the Draeger Battery

The Drager Narkomed 2B is one of their longest running and most reliable model lines. The 2B has O2 and N2O standard with optional medical air and holds 3 vaporizers. An AVE ventilator with F-Style ascending bellows is a standard feature with oxygen, volume & pressure monitoring. Drawer pack configurations may vary from picture.

Features of the Drager Narkomed 2B Anesthesia Machine:

- 19.1 and 19.3 vaporizers available ORM standard; ORMC optional - Ventilator options: Pneumatic or electronic, ascending or descending bellows - Oxygen monitor and CO2 absorber standard - With battery such as Draeger MS14234 Battery, Draeger Medical GAMMA Battery, Draeger Medical MS18340 Battery, Siemens SC9000XL Battery, Siemens SC7000 Battery, Siemens Medical Syste SC7000 Battery, Comen CM-100 Battery, Comen ICR18650 Battery, Comen CM-1200A Battery, Comen G60 Battery, Comen G50 Battery, Comen HYLB-1010 Battery - AVE Electronic ventilator - Absorber and scavenger - Oxygen analyzer - Breathing pressure monitor - Respiratory volume - Centralized alarm and data - Oxygen ratio controller - Pressure limit controller The NARKOMED 2B Anesthesia System is equipped with conductive casters. All anesthesia machines are tested for electrical conductivity between one caster as a measuring point and the table-top, shelf-top, and inspiratory valve, alternately, as the other measuring point. The maximum allowable resistance between any two points is 250,000 ohm.

Gas Delivery System Information:

Standard Gases: The Narkomed 2B is equipped with pneumatic circuitry for the delivery of oxygen (o2) and nitrous oxide (N2O). It has at least on oxygen and one nitrous oxide yoke for reserve gas cylinders with flush-type valves. The Pin Index Safety System prevents connection of a cylinder of the incorrect type.

Option Gases: In addition to oxygen and nitrous oxide, the NARKOMED 2B may be equipped with up to two additional gases. The additional gas may be air, helium, (He), nitrogen (N2), or carbon dioxide (CO2). The additional gas may be supplied to the anesthesia system by means of pin-indexed cylinders and yokes, by Diameter Indexed Safety System (DISS) pipeline connections, or by both systems, if so selected.